Initiator Pharma AS (OSTO:INIT) Net Loan

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:INIT Initiator Pharma AS OSTO:INIT
23 GF Score
Price kr2.35
! 1 Warning Sign
View Full Analysis

What is Initiator Pharma AS Net Loan?

Net Loan only applies to banks and insurance companies.

OSTO:INIT
23GF Score
Initiator Pharma AS OSTO:INIT
Net Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Initiator Pharma AS Business Description

Address Co/ COBIS, Ole Maaloesvej 3, Copenhagen, DNK, 2200
Initiator Pharma AS is a Danish clinical-stage life science company developing drugs that target key unmet medical needs within the central and peripheral nervous system. Its pipeline consists of three clinical programs: IP2018 and pudafensine for the treatment of erectile dysfunction of psychogenic and organic origin, respectively.
23GF Score

Get the complete analysis for OSTO:INIT

Net Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.35
Price